Lower brain fatty acid amide hydrolase in treatment-seeking patients with alcohol use disorder: a positron emission tomography study with [C-11]CURB

The endocannabinoid enzyme, fatty acid amide hydrolase (FAAH), has been proposed as a therapeutic target for alcohol use disorder (AUD) and co-morbid psychiatric illnesses. Investigating this target in the living human brain and its relationship to clinical outcome is a critical step of informed dru...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuropsychopharmacology
Main Authors: Best, Laura M., Williams, Belinda, Le Foll, Bernard, Mansouri, Esmaeil, Bazinet, Richard P., Lin, Lin, De Luca, Vincenzo, Lagzdins, Dina, Rusjan, Pablo, Tyndale, Rachel F., Wilson, Alan A., Hendershot, Christian S., Heilig, Markus, Houle, Sylvain, Tong, Junchao, Kish, Stephen J., Boileau, Isabelle
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7298050/
https://ncbi.nlm.nih.gov/pubmed/31910433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-0606-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares